PlushCare Tirzepatide: Dual-Agonist Program and Pathways

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This review is part of the PlexusDx Education Hub, covering GLP-1 therapies, weight-management protocols, and the genetic detail that underlies how any of them work. Browse all Peptides & GLP-1 education

This is independent editorial commentary. PlexusDx maintains no commercial relationship with PlushCare or its parent, and no affiliate links or payments are involved.

This page focuses on one compound: tirzepatide, and how a telehealth service like PlushCare prescribes and dispenses it. We look at what makes tirzepatide mechanistically distinct, the branded and compounded routes, and the trial record behind it. Editorial balance, not a buying nudge. Accurate as of April 2026.

What makes tirzepatide different

Tirzepatide is not a single-pathway GLP-1 drug — it is a dual GIP and GLP-1 receptor agonist, activating two incretin pathways at once. That dual action is why it is usually discussed separately from semaglutide. It underlies the branded products many people recognize and is a frequent second consideration in telehealth weight programs.

How PlushCare handles a tirzepatide script

Within PlushCare's Accolade-run subscription telehealth model, a tirzepatide prescription moves through the same clinical gate as any other: intake submission, licensed-clinician review, an eligibility check, and then routing to either a retail pharmacy for an FDA-approved brand product or a 503A compounding pharmacy for compounded tirzepatide, followed by titration support. The live details sit on PlushCare's official website.

Why the dispensing route is worth asking about

Because tirzepatide can arrive as a branded retail product or a 503A-compounded preparation, the fulfillment path affects form, dose availability, and price. It is a reasonable question to raise with the prescriber before you start.

Compounded tirzepatide and the branded alternatives

Branded tirzepatide is FDA-approved and dispensed at retail; compounded tirzepatide is prepared by 503A pharmacies against a prescription. The compounded route commonly addresses access and cost, but it is not the FDA-approved product, and that difference belongs in a conversation with your clinician. Suitability is individual — neither route wins by default.

The tirzepatide evidence base

Tirzepatide's weight-management data comes primarily from the SURMOUNT program, published in The New England Journal of Medicine in 2022, with SURMOUNT-OSA (NEJM 2024) extending the evidence into obstructive sleep apnea. These are distinct from the semaglutide STEP trials (NEJM 2021). Populations and endpoints differ across programs, and individual results vary.

Why two people respond differently to tirzepatide

The variable a telehealth intake cannot see is genetic. Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor tirzepatide engages alongside GIP), MC4R (a satiety and energy-balance receptor), and TCF7L2 (linked to glucose control and GLP-1 secretion) sketch the metabolic baseline any dual agonist acts on. They are pathway-level: not a prediction of tirzepatide's effect, but a description of the biology behind it.

Ahead of any GLP-1 protocol, the Precision Peptide Genetic Test examines 14 pathways, 49 peptides, 150+ genetic insights — including the FTO, MC4R, and TCF7L2 markers shaping appetite and energy-balance biology. That is the test before you invest principle: know your pathway, then talk it through with your provider. The test does not predict response to any specific medication.

Not affiliated: PlexusDx has no affiliation or commercial relationship with PlushCare or any brand referenced here.

Tirzepatide through PlexusDx

PlexusDx offers tirzepatide within its Weight Management Protocols as Tirzepatide Injection at $289/month and Tirzepatide Oral, alongside Semaglutide Injection and Semaglutide Oral. All are 503A-compounded. What sets the approach apart is the genetic context paired with the protocol, not the molecule on its own.

Related reading on PlexusDx: Mounjaro 25, Generic Mounjaro, Weight Loss Mounjaro, Mounjaro 75.

Disclaimer: This article is educational. PlexusDx is not affiliated with PlushCare and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare approaches: see the PlexusDx Weight Management Protocols for tirzepatide with genetic context, or take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions

How is tirzepatide different from semaglutide?

Semaglutide activates the GLP-1 receptor alone, while tirzepatide is a dual agonist acting on both the GIP and GLP-1 receptors. That two-pathway mechanism is the main pharmacological distinction. Which one is appropriate for a given person depends on clinical factors your prescriber weighs during evaluation.

Is compounded tirzepatide the same as the branded product?

It shares the active compound but is not the FDA-approved brand. Compounded tirzepatide is prepared by a 503A pharmacy per prescription and can differ in form and dose availability. Whether the compounded or branded route fits you is a decision to make with your clinician.

What does the SURMOUNT trial tell me about tirzepatide?

SURMOUNT (NEJM 2022) is the core weight-management evidence for tirzepatide, and SURMOUNT-OSA (NEJM 2024) extended it to sleep apnea. Trial populations and endpoints differ from real-world use, so the results describe study conditions rather than a guarantee of your individual outcome.

Can the genetic test predict my tirzepatide results?

No. The Precision Peptide Genetic Test does not forecast response to tirzepatide or any medication. It maps pathway-level variants like FTO and MC4R, and TCF7L2 that describe baseline metabolic biology — context for an informed conversation with your provider, not a prediction of drug effect.

This review is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.